
Romosozumab
Also called: Evenity
What it means
Romosozumab (brand name Evenity) is an anabolic osteoporosis medication given by injection that blocks sclerostin, a signal that normally holds bone formation back, allowing new bone to be built.
Understanding how this medication works helps you have an informed conversation with your prescriber about whether it fits your bone-building plan.
Romosozumab, sold as Evenity, belongs to the anabolic family of osteoporosis medications, alongside teriparatide and abaloparatide. Rather than slowing down the cells that break down bone, it works by blocking sclerostin — the same signaling molecule that osteocytes normally release to put the brakes on bone formation. By blocking that signal, romosozumab frees osteoblasts to build new bone tissue.
This mechanism is interesting because it's conceptually closest to what mechanical loading does in the body biologically, since loading also reduces sclerostin signaling naturally. Anabolic agents like romosozumab tend to produce larger bone density gains than antiresorptive drugs, which is part of why they are typically reserved for people at higher risk.
Romosozumab is time-limited by design, usually used for 12 to 24 months, and the gains it produces aren't self-sustaining on their own — standard practice is to follow it with an antiresorptive medication to help hold onto the bone that was built. It also carries a cardiovascular warning, which makes careful patient selection important. Any decision about starting, continuing, or switching from this medication belongs with your prescriber, who can weigh your individual risk factors.
How sure is this?
Graded Strong Clinical Evidence: Supported by multiple well-designed clinical studies in humans. Read each study with its grade in mind. One study is a piece of the picture, not the whole of it.
Where the Academy teaches it
This page is the short version. The lessons teach it in full, with the context around it and a quiz to lock it in.
Related words

Anabolic bone agents are medications, like teriparatide, abaloparatide, and romosozumab, that stimulate the body to…

Teriparatide (Forteo) is a daily injected medication that stimulates bone-building cells to form new bone, rather…

Abaloparatide (Tymlos) is a daily injectable medication that stimulates bone-building cells to form new bone, used…

Sclerostin is a protein made by bone cells called osteocytes that blocks new bone formation; less mechanical strain…

Antiresorptive medications, like bisphosphonates and denosumab, slow down the cells that break down old bone,…

Bisphosphonates are osteoporosis medications — like alendronate, risedronate, and zoledronic acid — that slow down…
Education only, not medical advice. Decisions about tests, medications and treatment belong with your own doctor. OsteoStrong does not diagnose, treat or cure any disease.


